Safety Study of a Helper Peptide Vaccine Plus Adjuvant Combinations for the Treatment of Melanoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Melanoma
Related studies linked through entity extraction aliases.
In Situ, Autologous Therapeutic Vaccination Against Solid Cancers With Intratumoral Hiltonol®
- Status
- COMPLETED
- Phase
- PHASE2
Evaluation of Intraoperative Usage of Sentinella in Detecting Sentinel Lymph Nodes
- Status
- COMPLETED
- Phase
- NA
Access Study of Trametinib for Subjects With Advanced Unresectable (Stage IIIc) or Distant Metastatic (Stage IV) BRAF V600E/K Mutation Positive Cutaneous Melanoma
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Evaluation of the Safety and Tolerability of i.v. Administration of a Cancer Vaccine in Patients With Advanced Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
Evaluating the Combination of MK-3475 and Sterotactic Body Radiotherapy in Patients With Metastatic Melanoma or NSCLC
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Trial of SBRT With Concurrent Ipilimumab in Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
Phase I/II Study of PDR001 in Patients With Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Ipilimumab and All-Trans Retinoic Acid Combination Treatment of Advanced Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
A Phase II Trial of Sunitinib and Nivolumab for KIT-mutated Advanced Melanoma
- Status
- WITHDRAWN
- Phase
- PHASE2
Analysis of Skin Lesions for Melanoma Presence by Volatile Spectroscopy Techniques
- Status
- COMPLETED
- Phase
- N/A
Efficacy Study of Nivolumab Compared to Ipilimumab in Prevention of Recurrence of Melanoma After Complete Resection of Stage IIIb/c or Stage IV Melanoma
- Status
- COMPLETED
- Phase
- PHASE3
A Study of rSIFN-co in Subjects With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Phase 1b Safety Study of CMB305 in Patients With Locally Advanced, Relapsed, or Metastatic Cancer Expressing NY-ESO-1
- Status
- TERMINATED
- Phase
- PHASE1
A Phase I/II Trial to Evaluate a Peptide Vaccine Plus Ipilimumab in Patients With Melanoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Training Primary Care Physicians to Perform Melanoma Opportunistic Surveillance
- Status
- COMPLETED
- Phase
- NA
A Clinical Trial to Evaluate a Melanoma Helper Peptide Vaccine Plus Dabrafenib and Trametinib
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
Safety Study of Enoblituzumab (MGA271) in Combination With Ipilimumab in Refractory Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Safety Study of SEA-CD40 in Cancer Patients
- Status
- TERMINATED
- Phase
- PHASE1
Improving Goals of Care Discussion in Advanced Cancer Patients
- Status
- COMPLETED
- Phase
- NA